Advances in the Management of Classical Hodgkin Lymphoma
Advances in the management of Hodgkin lymphoma (HL) and development of more effective treatment options over the last few decades have led to improvements in 5-year survival rates, with HL considered to be among the most curable of malignancies with modern treatments.
  • Hodgkin Lymphoma
  • Recorded Webcast
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation